FDA
-
-
-
-
-
-
-
Humacyte to Present at the H.C. Wainwright 28th Annual Global Investment Conference
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on Humacyte (HUMA)
-
-
-
-
-
-
-
Humacyte reports bioengineered blood vessel beats standard care for women on dialysis
-
-
-
-
-
-
-
Humacyte announces public offering of common stock
-
-
-
-
-
-
-
HUMACYTE's Symvess receives VA contract for 170 hospitals
-
-
-
-
-
-
-
Humacyte realigns ex-US rights to Symvess with Fresenius Medical Care
-
-
-
-
-
-
-
Humacyte appoints Rick McElheny as senior VP of business development
-
334,272 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


